No abstract

Previous in vivo observations in rats have shown that poly(ethylene glycol) polyhexadecylcyanoacrylate (PEG-PHDCA) nanoparticles could translocate into the brain after intravenous injection, which polyhexadecylcyanoacrylate (PHDCA) nanoparticles did not. Through the detailed analysis of the plasma protein adsorption onto the surface of PEG-PHDCA nanoparticles, the present study aimed at clarifying the mechanism by which nanoparticles could penetrate into rat brain endothelial cells (RBEC). Two-dimensional polyacrylamide gel electrophoresis and Western blotting revealed that, after incubation with rat serum, apolipoprotein E (ApoE) adsorbed more onto PEG-PHDCA than on PHDCA nanoparticles. Adsorption of apolipoprotein B-100 (ApoB-100) onto PEG-PHDCA nanoparticles was demonstrated by capillary electrophoresis experiments. Moreover, only when ApoE or ApoB-100 were preadsorbed onto PEG-PHDCA nanoparticles, nanoparticles were found to be more efficient than control nanoparticles for penetrating into RBEC, suggesting the involvement of a low density lipoprotein receptor in this process. Thus, these data clearly demonstrate the involvement of apolipoproteins in the brain transport of PEG-PHDCA nanoparticles, which may open interesting prospects for brain drug delivery.

The concept of chelation-assisted copper catalysis was employed for the development of new azides that display unprecedented reactivity in the copper(I)-catalyzed azide-alkyne [3+2] cycloaddition (CuAAC) reaction. Azides that bear strong copper-chelating moieties were synthesized; these functional groups allow the formation of azide copper complexes that react almost instantaneously with alkynes under diluted conditions. Efficient ligation occurred at low concentration and in complex media with only one equivalent of copper, which improves the biocompatibility of the CuAAC reaction. Furthermore, such a click reaction allowed the localization of a bioactive compound inside living cells by fluorescence measurements.

The discovery of new chemical reactions is a long-standing goal of organic chemists. For decades, synthetic problems motivated the development of new methodologies to continuously expand the reaction toolkit in organic synthesis. As alternatives to purely rational approaches, strategies that offer more room for serendipity have recently emerged. In these approaches, the discovery is a result of the systematic exploration of a large number of chemical reactions through the use of robust high-throughput screening methods based either on mass spectrometry techniques [1] or on DNA technologies. [2] Although this strategy was already proven to be efficient with the discovery of several new interesting reactions, [3] this does not guarantee the potential impact of the discovered reactions. A more powerful approach would be the increase of the level of selection in a manner that only powerful reliable reactions are discovered. Such a highly demanding selection should therefore be based not only on reaction efficiencies, but also on other parameters that would ensure the usefulness of the discovered reaction. In 2001, K. B. Sharpless introduced the concept of "click chemistry", which has been widely and successfully applied since then, and listed a series of important criteria that may influence the extent and the impact of a chemical reaction. [4] Among them, chemoselectivity, simplicity of reaction conditions, and high efficiency, even in complex media, are probably the most important ones. This can be highlighted by the startling number of applications in organic synthesis, materials science, and biotechnology of the copper-catalyzed alkyne-azide cycloaddition reaction (CuAAC), which is one of the most powerful click reactions described to date. [5] Herein, we disclose an approach to accelerate the discovery of such important chemical reactions through the use of an immunoassay technique. As we previously described, [6] sandwich immunoassays can be successfully applied to monitor cross-coupling reactions by connecting small-molecule tags to chemically reactive groups. Products of bond-forming coupling reactions can then be specifically detected by two specific antitag monoclonal antibodies (mAbs) using standard ELISA techniques: one mAb captures the doubletagged coupling product on a solid phase and a second acts as a detector. We recently showed that the throughput of this adapted immunoassay (typically around 1000 analyses per day and person) allows the fast identification of new reactions among thousands of combinations of reactive functions and catalysts. [7] One crucial advantage of this screening method relies on the high specificity of mAbs, permitting the precise and sensitive quantification of the double-tagged crosscoupling products in complex mixtures without work-up. Here, we decided to fully exploit this advantage by designing a series of successive screening in order to identify new, efficient, chemoselective, and biocompatible [3+2] cycloaddition reactions. Our approach (Figure 1) involves three mai...

A copper-catalyzed procedure enabling dynamic carbon isotope exchange is described. Utilizing the universal precursor [ 14 C]CO 2 , this protocol allows to insert, in one single step, the desired carbon tag into carboxylic acids with no need of structural modifications. Reducing synthetic costs and limiting the generation of radioactive waste, this procedure will facilitate the access to carboxylic acids containing drugs and accelerate early 14 C-based ADME studies supporting drug development.

The biodistribution of colloidal carriers after their administration in vivo depends on the adsorption of some plasma proteins and apolipoproteins on their surface. Poly(methoxypolyethyleneglycol cyanoacrylate-co-hexadecylcyanoacrylate) (PEG-PHDCA) nanoparticles have demonstrated their capacity to cross the blood-brain barrier (BBB) by a mechanism of endocytosis. In order to clarify this mechanism at the molecular level, proteins and especially apolipoproteins adsorbed at the surface of PEG-PHDCA nanoparticles were analyzed by complementary methods such as CE and Protein Lab-on-chip in comparison with 2-D PAGE as a method of reference. Thus, the ability of those methodologies to identify and quantify human and rat plasma protein adsorption onto PEG-PHDCA nanoparticles and conventional PHDCA nanoparticles was evaluated. The lower adsorption of proteins onto PEG-PHDCA nanoparticles comparatively to PHDCA nanoparticles was evidenced by 2-D PAGE and Protein Lab-on-chip methods. CE allowed the quantification of adsorbed proteins without the requirement of a desorption procedure but failed, in this context, to analyze complex mixtures of proteins. The Protein Lab-on-chip method appeared to be very useful to follow the kinetic of protein adsorption from serum onto nanoparticles; it was complementary to 2-D PAGE which allowed the identification (with a relative quantification) of the adsorbed proteins. The overall results suggest the implication of the apolipoprotein E in the mechanism of passage of PEG-PHDCA nanoparticles through the BBB.

Poly(methoxypolyethyleneglycol cyanoacrylate-co-hexadecylcyanoacrylate) (PEG-PHDCA) nanoparticles have demonstrated their capacity to diffuse through the blood-brain barrier after intravenous administration. However, the mechanism of transport of these nanoparticles into brain has not yet been clearly elucidated. The development of a model of rat brain endothelial cells (RBEC) in culture has allowed investigations into this mechanism. A study of the intracellular trafficking of nanoparticles by cell fractionation and confocal microscopy showed that nanoparticles are internalized by the endocytic pathway. Inhibition of the caveolae-mediated pathway by preincubation with filipin and nystatin did not modify the cellular uptake of the nanoparticles. In contrast, chlorpromazine and NaN(3) pretreatment, which interferes with clathrin and energy-dependent endocytosis, caused a significant decrease of nanoparticle internalization. Furthermore, cellular uptake experiments with nanoparticles preincubated with apolipoprotein E and blocking of low-density lipoprotein receptors (LDLR) clearly suggested that the LDLR-mediated pathway was involved in the endocytosis of PEGPHDCA nanoparticles by RBEC.

Clean and green: Copper(I) complexes of phenanthroline‐based ligands anchored on the chitosan polymer are good catalysts for the “click” cycloaddition of azides with terminal alkynes (see scheme; the scanning electron microscopy image shows the porous structure of the catalyst). These heterogeneous catalytic systems do not require a base or reducing agent and operate in alcohol or water.